Todd C. Davis, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), bought 19,020 shares at $104.57 ($2.0M) on 2025-05-09, disclosed to the SEC on 2025-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.53 | 2,307 | $241K | 12.1% |
| 2 | $104.53 | 2,307 | $241K | 12.1% |
| 3 | $104.57 | 1,680 | $176K | 8.8% |
| 4 | $104.57 | 1,680 | $176K | 8.8% |
| 5 | $105.67 | 5,523 | $584K | 29.2% |
| 6 | $105.67 | 5,523 |
| $584K |
| 29.2% |
| Total | $105.20 avg | 19,020 | $2.0M | 100% |
| Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |
| BDSI | SELL | 2020-08-20 | $250K | — | Filing → |